Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine GITS vs Amlodipine Besylate in Non-dipper Hypertension
NCT02940548Phase 4Terminated
- Start
- Dec 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nifedipine in hypertension (HTN) (4 arms). Primary endpoint: Nighttime systolic blood pressure reduction at 8 weeks. Started Dec 2016; status: terminated.
02
Drugs
nifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02940548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940548.